These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7979108)

  • 1. Drug treatment of hypercholesterolaemia in a patient with Gilbert's syndrome.
    Cummings MH; Watts GF
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():383-5. PubMed ID: 7979108
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patients.
    Branchi A; Rovellini A; Fiorenza AM; Sommariva D
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):345-50. PubMed ID: 7582386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia.
    Cutler N; Sramek J; Veroff A; Block G; Stauffer L; Lines C
    Br J Clin Pharmacol; 1995 Mar; 39(3):333-6. PubMed ID: 7619678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia.
    Branchi A; Rovellini A; Sommariva D; Gugliandolo AG; Fasoli A
    Thromb Haemost; 1993 Aug; 70(2):241-3. PubMed ID: 8236126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatotoxicity of isotretinoin in patients with acne and Gilbert's syndrome: a comparative study.
    Fernández-Crehuet P; Fernández-Crehuet JL; Allam MF; Fernández-Crehuet Navajas R
    BMJ Open; 2014 Mar; 4(3):e004441. PubMed ID: 24650805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.
    Eckernäs SA; Roos BE; Kvidal P; Eriksson LO; Block GA; Neafus RP; Haigh JR
    Br J Clin Pharmacol; 1993 Mar; 35(3):284-9. PubMed ID: 8471404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison about the efficacy and tolerability between simvastatin and bezafibrate in the treatment of hypercholesterolemia].
    Bruckert E; Truffert J; De Gennes JL
    Ann Med Interne (Paris); 1991; 142(7):505-10. PubMed ID: 1789528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin.
    Illingworth DR; Erkelens DW; Keller U; Thompson GR; Tikkanen MJ
    Lancet; 1994 Jun; 343(8912):1554-5. PubMed ID: 7911877
    [No Abstract]   [Full Text] [Related]  

  • 9. [The mechanism of action of hypolipidemic drugs].
    Scheen AJ
    Rev Med Liege; 1997 Jun; 52(6):445-6. PubMed ID: 9289779
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemorheologic and coagulative pattern in hypercholesterolemic subjects treated with lipid-lowering drugs.
    Bo M; Bonino F; Neirotti M; Gottero M; Pernigotti L; Molaschi M; Fabris F
    Angiology; 1991 Feb; 42(2):106-13. PubMed ID: 2006757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins].
    Kłosiewicz-Latoszek L; Nowicka G; Szostak WB
    Wiad Lek; 1993 Aug; 46(15-16):581-5. PubMed ID: 7975581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of systemic treatment with statins on skin barrier function and stratum corneum water-holding capacity.
    Brazzelli V; Distante F; Perani G; Berardesca E
    Dermatology; 1996; 192(3):214-6. PubMed ID: 8726633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats.
    Joles J; Willekes-Koolschijn N; Koomans H; Van Tol A; Geelhoed-Mieras T; Crommelin D; Van Bloois L; Krajnc-Franken M; Cohen L; Griffioen M
    Lab Anim; 1992 Oct; 26(4):269-80. PubMed ID: 1447905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Substantiation of increasing doses of statins in clinical practice].
    Susekov AV
    Ter Arkh; 2001; 73(4):76-80. PubMed ID: 11494456
    [No Abstract]   [Full Text] [Related]  

  • 15. Implications of 4S evidence on baseline lipid levels.
    Ravnskov U
    Lancet; 1995 Jul; 346(8968):181. PubMed ID: 7603244
    [No Abstract]   [Full Text] [Related]  

  • 16. Colestipol tablets in adolescents with familial hypercholesterolaemia.
    Tonstad S; Ose L
    Acta Paediatr; 1996 Sep; 85(9):1080-2. PubMed ID: 8888922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
    Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotretinoin-associated normalization of hyperbilirubinemia in patients with Gilbert's syndrome.
    Wang JI; Jackson TL; Kaplan DL
    J Am Acad Dermatol; 1995 Jan; 32(1):136-8. PubMed ID: 7822509
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reductions in lipid fraction plasma levels induced by simvastatin and bezafibrate. Brazilian multicenter study].
    Forti N
    Arq Bras Cardiol; 1993 Jun; 60(6):437-44. PubMed ID: 8279987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia].
    Caruzzo C; Uslenghi E; Varbella F; Caruzzo E; Marcolongo M; Brusca A
    Minerva Cardioangiol; 1989 Dec; 37(12):509-15. PubMed ID: 2695857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.